Huidong Shi
- Molecular Biology top 0.5%
- Epigenetics and DNA Methylation 70
- RNA modifications and cancer 37
- Cancer-related gene regulation 21
- Genomics and Chromatin Dynamics 13
- Biological Psychiatry top 2%
- Cancer Research top 1%
- Immunology top 2%
- Immune Cell Function and Interaction 15
- Immune cells in cancer 13
- Oncology top 2%
-
- Chronic Lymphocytic Leukemia Research 15
-
- Monoclonal and Polyclonal Antibodies Research 9
- Co-authors
- David H. MunnPearlly S. YanMuthusamy ThangarajuVadivel GanapathyCharles W. CaldwellNagendra SinghPuttur D. PrasadSanthakumar Manicassamy
- Partner nations
- United StatesChinaGeorgia
In The Last Decade
Huidong Shi
173 papers receiving 8.7k citations
Hit Papers
Peers
Comparison fields: 5 of 154
- Molecular Biology 6.2k
- Biological Psychiatry 222
- Cancer Research 1.1k
- Immunology 1.3k
- Oncology 1.2k
Countries citing papers authored by Huidong Shi
This map shows the geographic impact of Huidong Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huidong Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huidong Shi more than expected).
Fields of papers citing papers by Huidong Shi
This network shows the impact of papers produced by Huidong Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huidong Shi. The network helps show where Huidong Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Huidong Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 1 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 9 | |
| 8 | 2022 | 30 | |
| 9 | 2022 | 36 | |
| 10 | 2021 | 17 | |
| 11 | 2021 | 56 | |
| 12 | 2020 | 61 | |
| 13 | 2020 | 141 | |
| 14 | 2020 | 50 | |
| 15 | 2018 | 10 | |
| 16 | 2018 | 23 | |
| 17 | 2014 | 69 | |
| 18 | 2013 | 117 | |
| 19 | 2007 | 178 | |
| 20 | 2007 | 109 |
About Huidong Shi
Huidong Shi is a scholar working on Genetics, Molecular Biology and Biological Psychiatry, having authored 183 papers that have together received 8.8k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (70 papers), RNA modifications and cancer (37 papers), Cancer-related gene regulation (21 papers), Chronic Lymphocytic Leukemia Research (15 papers), Immune Cell Function and Interaction (15 papers), Genomics and Chromatin Dynamics (13 papers), Immune cells in cancer (13 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Molecular Biology (6.2k citations), Biological Psychiatry (222 citations) and Cancer Research (1.1k citations). Huidong Shi has collaborated with scholars based in United States, China and Georgia. Frequent co-authors include David H. Munn, Pearlly S. Yan, Muthusamy Thangaraju, Vadivel Ganapathy, Charles W. Caldwell, Nagendra Singh, Puttur D. Prasad, Santhakumar Manicassamy, Ravi N. Padia and Ashish Gurav. Their work appears in journals such as Nucleic Acids Research, Circulation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.